JUL 27, 2017 5:33 AM PDT

Scientists Shed Light on New Brain Cancer Targets

WRITTEN BY: Xuan Pham

Brain cancer is on higher on the discussion list this week after news broke of Senator John McCain’s recent glioblastoma diagnosis. The news remind us of that cancer doesn’t discriminate, and that we are all fallible. But, instead of being frightened, let’s talk about what some scientists are doing to better understand and treat this infamous disease.

Image credit: Pixabay.com

At a cancer laboratory at Case Western Reserve University, a team of scientists, led by Drs. Jeremy Rich and Paul Tesar, is uncovering the genes that enable brain tumors to thrive. Knowing these genes, they reasoned, could give us the precise targets to stop their growth and extend survival.

The team began with human glioblastoma cells which they either maintained in a dish, or  transplanted into mice to mimic natural tumor biology. They then profiled the genes in the two tumor environments to pinpoint those that are essential to tumor survival. This led to the identification of 57 genes that differed between the two environments. This 57 genes seemed to be involved in the animal model of the brain tumor, suggesting 57 new targets at which to aim.

"There was very little overlap of the targets identified in the new in vivo screening method and the traditional cell culture screen," said Dr. Jeremy Rich, the study’s co-senior author, who is now a professor at the University of California San Diego. "This means the field has been missing a number of potential therapeutic targets that may actually improve patient outcomes and prolong survival."

Further investigation into the 57 genes revealed that 12 of the genes are involved with how cancer cells respond to stress. When genes in this pathway were inhibited, the mice had extended survival while tumor cells in culture showed no effect.

"Our study found that in a natural environment, tumor cells are more susceptible to inhibition of their stress response mechanisms,” said Dr. Tyler Miller, the study’s first author. “Current chemotherapies all target proliferating, or dividing cells. We know that type of therapy doesn't work for glioblastoma. Our findings suggest that targeting the stress response may be better at slowing tumor growth than targeting cell proliferation, which opens up a new avenue for therapeutic development."

Glioblastoma is often nicknamed “octopus tumor” because the malignant glial cells form vast networks of tendrils throughout the brain. This makes it extremely difficult to completely get rid of the tumor. As such, the brain cancer can evade even the most aggressive surgeries, chemotherapies, and radiotherapies, leaving patients with a five-year survival rate of less than 10 percent. Over 70 percent of patients diagnosed with this type of brain cancer rarely survive past the two-year mark.

"Prior attempts at discovering therapeutic targets have generally been done in cell culture, that is, patient cells on plastic dishes in artificial media to help them grow. The hope is that systems like ours that more closely mimic the natural tumor environment will identify new targets that better translate into effective therapies for patients,” said Dr. Paul Tesar, a distinguished professor at Case Western University School of Medicine, and the study’s other co-senior author. Indeed, the team hopes their approach will shed more light on how to treat this cancer and other cancer types as well.

Additional sources: Case Western Reserve University

 

About the Author
  • I am a human geneticist, passionate about telling stories to make science more engaging and approachable. Find more of my writing at the Hopkins BioMedical Odyssey blog and at TheGeneTwist.com.
You May Also Like
NOV 18, 2019
Cancer
NOV 18, 2019
UV light targets hyperhotspots for skin cancer
New research published in Proceedings of the National Academy of Sciences suggests that certain “hyperhotspots” in the human genome can be pinp...
NOV 25, 2019
Cell & Molecular Biology
NOV 25, 2019
Linking Intestinal Stem Cells with Increased Cancer Risk From a High-Fat Diet
The work, which used a mouse model, links stem cell activity with cellular fat consumption in a new way....
DEC 25, 2019
Drug Discovery & Development
DEC 25, 2019
New Drug to Make Breast Cancer Treatment More Affordable
The US Food and Drug Administration has granted accelerated approval to new breast cancer drug, trastuzumab deruxtecan. The drug’s increasing recogni...
JAN 08, 2020
Health & Medicine
JAN 08, 2020
Major Study Does Not Find Strong Link Between Talcum Powder and Cancer
Competing opinions regarding the safety of talcum powder have developed throughout the past several decades. Talc is commonly used as baby powder and is al...
FEB 14, 2020
Cancer
FEB 14, 2020
Cataloging Cancer: DNA fingerprints at work
New research published as part of a global Pan-Cancer Project highlights the world’s most comprehensive catalog to date of DNA fingerprints of cancer...
FEB 16, 2020
Cancer
FEB 16, 2020
Digital biopsies: coming soon to clinics near you
Research published recently in the Proceedings of the National Academy of Sciences reports the development of a digitized biopsy, one that could be co...
Loading Comments...